<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many studies have shown that the relationship between alcohol consumption and most <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> is U-shaped, with nondrinkers and heavier drinkers having higher risks than moderate drinkers </plain></SENT>
<SENT sid="1" pm="."><plain>However, the association between <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> alcohol consumption is not well understood </plain></SENT>
<SENT sid="2" pm="."><plain>We set up several experimental <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> animal models to examine the effects of <z:hpo ids='HP_0011009'>acute</z:hpo> administration of <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> on <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The results showed 0.4, 0.8 and 1.6 g/kg <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> consumption obviously delayed the <z:hpo ids='HP_0003674'>onset</z:hpo> time of <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) (P &lt; 0.05 or P &lt; 0.01) and increased the survival rates on <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>-CaCl₂-induced AF in mice </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="37" ids="16236,44730">Ethanol</z:chebi> (0.4, 0.8 and 1.6 g/kg) consumption significantly delayed the <z:hpo ids='HP_0003674'>onset</z:hpo> time of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT), <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) and <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo> (CA) (P &lt; 0.01), and 0.4 and 0.8 g/kg <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> consumption increased the survival rates on CaCl₂-induced <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in rats </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="37" ids="16236,44730">Ethanol</z:chebi> (0.4 g/kg) essentially increased the cumulative dosage of <z:chebi fb="0" ids="2430">aconitine</z:chebi> required to CA (P &lt; 0.05), and 0.8 g/kg, 1.6 g/kg <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> reduced the cumulative <z:chebi fb="0" ids="2430">aconitine</z:chebi> dosage to induce VT, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> and CA (P &lt; 0.05 or P &lt; 0.01) on <z:chebi fb="0" ids="2430">aconitine</z:chebi>-induced <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in rats </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="37" ids="16236,44730">Ethanol</z:chebi> (0.4, 0.8 and 1.6 g/kg) consumption remarkably increased the cumulative dosage of deslanoside to induce ventricualr premature contraction (P &lt; 0.01) on deslanoside-induced <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> in guinea pigs </plain></SENT>
<SENT sid="7" pm="."><plain>Collectively, our results indicate that low concentrations of <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> had anti-arrhythmic effect on experimental <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, and high concentrations of <z:chebi fb="37" ids="16236,44730">ethanol</z:chebi> may aggravated the occurrence of experimental <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>